About the Blending Initiative:
Accelerating the dissemination of research-based drug abuse treatment into clinical practice is a priority for the National Institute on Drug Abuse (NIDA) and represents the core mission of the Blending Initiative. NIDA and the Substance Abuse and Mental Health Services Administration (SAMHSA) joined together to create the Blending Initiative in 2001 to reduce the gap that exists between the publication of research results and impact on treatment delivery. This initiative incorporates collaboration between clinicians, scientists, and experienced trainers to catalyze the creation of user-friendly treatment tools and products and facilitate the adoption of research-based interventions into front-line clinical settings. Through this initiative, NIDA and SAMHSA’s Addiction Technology Transfer Centers (ATTCs) disseminate treatment and training products based on results from studies conducted by the National Drug Abuse Clinical Trials Network (CTN) as well as other NIDA-supported research. For additional information on the Blending Initiative, contact:
Joanna Weston, MPH
Email: JWeston@leedmci.com
The Blending Initiative comprises three components:
- Blending Products and Materials;
- Blending Meetings and Conferences; and
- Collaborative Partnerships
Through these components, and together with SAMHSA, NIDA facilitates the adoption of research-based interventions into front-line clinical settings.
Products & Materials:
NIDA Blending Products and Materials constitute a primary mode of research translation toward clinical practice in the drug abuse field. Blending Teams, consisting of NIDA researchers, treatment practitioners, trainers from SAMHSA’s ATTC Network, NIDA staff, and subject matter and communications experts, work closely together to develop training curricula, manuals, tools, and other resource materials based on NIDA-supported research. Blending Products introduced into the field have covered such topics as Motivational Interviewing, HIV Rapid Testing, Motivational Incentives/Contingency Management, and Buprenorphine Treatment for Opioid Use Disorders. Recent efforts have included an infographic on the role of Smoking Cessation in Addiction Treatment, along with web-based simulation training for Motivational Interviewing.
- HIV Rapid Testing in Substance Abuse Treatment Programs: Resources to Support On-Site Rapid Testing (2012)
- Buprenorphine Suite of Blending Products, which includes:
- Buprenorphine Treatment: Training for Multidisciplinary Addiction Professionals (2005)
- Short-Term Opioid Withdrawal Using Buprenorphine: Findings and Strategies from a NIDA Clinical Trials Network (CTN) Study (2006)
- Buprenorphine Treatment for Young Adults (2010)
- The Prescription Opioid Addiction Treatment Study (POATS): Treatment Strategies for Prescription Opioid Dependence and Information (2012)
- Motivational Incentives Package: A Proven Approach to Treatment, which includes:
- Promoting Awareness of Motivational Incentives (PAMI) (Revised 2011)
- Motivational Incentives: Positive Reinforcers to Enhance Successful Treatment Outcomes (MI:PRESTO) (2011)
- Motivational Incentives Implementation Software (MIIS) (2011)
- Motivational Interviewing Assessment: Supervisory Tools for Enhancing Proficiency (MIA:STEP) (2006)
- Treatment Planning M.A.T.R.S.: Utilizing the Addiction Severity Index (ASI) to Make Required Data Collection Useful (2005)
Meetings & conferences:
Another cornerstone of the Blending Initiative involves the planning and execution of Blending Meetings and Conferences. These unique events provide an opportunity to foster collaboration and knowledge exchange between drug abuse researchers and treatment providers. The events expose providers to cutting-edge, evidence-based treatments and offer continuing education credits for physicians, psychologists, nurses, social workers, and addiction counselors. With the support and involvement of NIDA researchers, federal partners, and professional organizations, the Blending Initiative has been advanced through a variety of hands-on, skill-building workshops and lectures for audiences ranging from addiction professionals to emergency department physicians. These activities also serve as opportunities for Blending Teams to meet with leadership and members of key organizations to initiate collaborative training activities, discuss partnership possibilities, and initiate resource development.
- 2015 - Update in Addiction Medicine for the General Internist - Toronto, Canada
- 2014
- March 23 - Screening, Brief Intervention and Referral to Treatment “SBIRT” in Adolescent Primary Care - Austin, Texas
- May 3 - Empowering Family Medicine Residencies to Address Prescription Opioid Abuse - San Antonio, Texas
- 2013
- October 13 - Effective Approaches to Addressing Patients with Substance Use Disorders in the Emergency Department: A Knowledge Exchange - Seattle, Washington
- November 10 - From START to Finish: National and International Perspectives on Dissemination Research to Practice for the Treatment of Opioid Dependence - Philadelphia, Pennsylvania
- 2012 - Accelerating Knowledge Exchange in Substance Abuse Treatment - Atlanta, Georgia
- 2010 - Evidence-Based Treatment and Prevention in Diverse Populations and Settings - Albuquerque, New Mexico
- 2008 - The Impact of Evidence-Based Practices on Individuals, Families and Communities - Cincinnati, Ohio
- 2006 - Bridges to the Future - Seattle, Washington
- 2005 - Smart Practice, Practical Science - Miami, Florida
- 2004 - Forging Partnerships in the Great Lakes Region to Enhance Drug Addiction Treatment - Detroit, Michigan
- 2003 - Forging Partnerships in the Rocky Mountain States to Enhance Drug Addiction Treatment - Westminster, Colorado
- 2002 - Forging Partnerships to Enhance Drug Addiction Treatment - New York, New York
- 2000 - Forging Partnerships to Enhance Drug Addiction Treatment - Los Angeles, California
Collaborative Partnerships:
The Blending Initiative aims to establish and maintain collaborative partnerships with professional organizations serving the addiction treatment community as well as general medical settings such as primary and emergency care. In recent years, the Blending Initiative has partnered with more than a dozen organizations to provide embedded conference sessions, preconference workshops, and specialty courses for buprenorphine credit waivers, along with training and mentorship awards. These collaborations are key to reaching the full spectrum of healthcare providers and professionals, as well as reaching health providers just beginning their career trajectory. One facet of the Blending Initiative’s efforts at collaboration is the distribution of resident mentorship opportunities. Beginning in 2012, the Blending Initiative began partnerships with a variety of organizations to facilitate the funding and management of these opportunities. Such organizations include the American Academy of Child and Adolescent Psychiatry, the American College of Emergency Physicians, the Society of Teachers of Family Medicine, and the Society for Adolescent Health and Medicine. These mentoring activities create a fantastic opportunity for NIDA and the Blending Initiative to encourage the early adoption and implementation of evidence-based substance use disorder treatment interventions in the general healthcare setting.